Abstract
This Special Issue of ChemMedChem on Epigenetics and Drug Discovery brings together a diverse group of papers on a range of topics from bromodomain inhibitors and long noncoding RNAs to classic agents targeting histone deacetylases (HDACs) and less typical HDAC inhibitors, such as the chimeric compounds designed by Greg Thatcher et al. and featured on the Front Cover of the issue that both target HDACs and act as selective estrogen receptor modulators (SERMs).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
